美股異動 |Fusion Pharmaceuticals 盤前飆漲 94% 阿斯利康擬溢價近一倍收購

第一財經
2024.03.19 08:22
臨牀階段生物製藥公司 Fusion Pharmaceuticals(FUSN.US) 盤前飆漲 94%，報 20.65 美元。消息上，阿斯利康週二表示，將以約 20 億美元現金收購 Fusion Pharmaceuticals，以擴大其腫瘤產品組合。阿斯利康將以每股 21 美元的價格收購 Fusion，較這家美國上市公司週一的收盤價溢價逾 97%。阿斯利康還將支付每股 3 美元的不可轉讓或有價值權，使合併交易價值達到
Source: 第一財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.